Loading...

IM Cannabis Corp.

IMCCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.80
$-0.01(-0.36%)

IM Cannabis Corp. (IMCC) Stock Overview

Explore IM Cannabis Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 59.1/100

Key Financials

Market Cap8.6M
P/E Ratio-2.52
EPS (TTM)$-1.40
ROE-0.79%
Fundamental Analysis

AI Price Forecasts

1 Week$4.04
1 Month$3.12
3 Months$0.00
1 Year Target$1.02

IMCC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of IM Cannabis Corp. (IMCC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.28, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.52 and a market capitalization of 8.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;